Inventor · disambiguated record
Jennifer Richardson
Also filed as: RICHARDSON JENNIFER · RICHARDSON JENNIFER H · RICHARDSON JENNIFER HOPE
8 granted patents·6 pending applications·313 citations·filing 1994–2023
89Inventor score
Files withABBVIE INC3CYTOMX THERAPEUTICS INC3MILLENNIUM PHARM INC3DANA FARBER CANCER INST INC2AMGEN FREMONT INC1
Top patents by PatentIndex Score
14 records- 0196US10669337B2Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the sameCYTOMX THERAPEUTICS INC·Filed 2015·Granted Jun 2, 2020·31 cites·16 claims
- 0289US6143520AExpression vectors and methods of useDANA FARBER CANCER INST INC·Filed 1998·Granted Nov 7, 2000·124 cites·9 claims
- 0389US6004940AIntracellular targeting of endogenous proteinsDANA FARBER CANCER INST INC·Filed 1994·Granted Dec 21, 1999·114 cites·32 claims
- 0485US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 0582US11802158B2Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the sameCYTOMX THERAPEUTICS INC·Filed 2020·Granted Oct 31, 2023·1 cites·21 claims
- 0677US2024084010A1Bispecific anti-cd3 antibodies, bispecific activatable anti-cd3 antibodies, and methods of using the sameCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0776US2024115724A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2023·Application pending·0 cites
- 0864US2019111150A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 0963US2021145978A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 1060US2009148834A1Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancersMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1155US6391304B1Peptides derived from the ENV gene of the feline immunodeficiency virus and their applicationsCENTRE NAT RECH SCIENT·Filed 1998·Granted May 21, 2002·20 cites·2 claims
- 1242US6355430B1Diagnostic and screening methods employing KIAA0101MILLENNIUM PHARM INC·Filed 1999·Granted Mar 12, 2002·8 cites·14 claims
- 1342US2002123081A1Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancersFiled 2001·Application pending·0 cites
- 1430US6485921B1UBCLP and uses thereofMILLENNIUM PHARM INC·Filed 1998·Granted Nov 26, 2002·3 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →